Trials / Withdrawn
WithdrawnNCT00837941
A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)
Qualification of Single Dose Administration of Analgesic Therapy in the Treatment of Chronic Neuropathic Pain in Patients With Painful Diabetic Neuropathy
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if analgesic efficacy can be detected with single dose administration in patients with chronic neuropathic pain due to painful diabetic neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Comparator: A: Pregabalin | 1 Pregabalin 300 mg capsule |
| DRUG | Comparator: B: Duloxetine | 1 Duloxetine hydrochloride 60 mg capsule |
| DRUG | Comparator: C: Diphenhydramine hydrochloride | 1 Diphenhydramine hydrochloride 25mg capsule |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2009-08-01
- Completion
- 2009-09-01
- First posted
- 2009-02-06
- Last updated
- 2015-07-27
Source: ClinicalTrials.gov record NCT00837941. Inclusion in this directory is not an endorsement.